Finra taps NYSE reg head Ketchum as chief

NYSE regulatory chief Richard Ketchum will be named the new chief executive of Finra, the Wall Street Journal reported today.
FEB 19, 2009
NYSE regulatory chief Richard Ketchum will be named the new chief executive of Finra, the Wall Street Journal reported today. Finra spokesman Herb Perone would not confirm the report, and a spokesman for NYSE Regulation Inc., of which Mr. Ketchum is currently chief executive, could not be reached for comment. Mr. Ketchum would succeed Mary Schapiro, who became chairman of the Securities and Exchange Commission in January. He has been chief executive officer of NYSE Regulation since 2006. NYSE Regulation is the regulatory arm of NYSE Euronext of New York. In addition to heading regulation for NYSE, Mr. Ketchum is non-executive chairman of Finra, and he has served as president of both the Nasdaq Stock Market Inc of New York and NASD, which merged with the regulatory arm of the former New York Stock Exchange to form Finra. Prior to working at NASD and Nasdaq, Mr. Ketchum spent 14 years at the SEC, where for eight years he was director of the division of market regulation, now the division of trading and markets. The Financial Industry Regulatory Authority Inc. is based in Washington and New York. Investment News first reported that Mr. Ketchum was a frontrunner for the position Jan. 29 ("Rumors fly over who’ll be next Finra CEO" ).

Latest News

Retiree alleges advisor withheld $600K through real estate LLC web
Retiree alleges advisor withheld $600K through real estate LLC web

$1.7M invested from an inheritance. Then the phone went dead.

SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception
SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception

The pre-IPO platform sold $430M in units while allegedly rigging prices behind the scenes.

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors
Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors

The hundreds of millions of dollars from a sale of Inspired Healthcare properties does not mean an immediate windfall for investors.

Class action alleges Webull misled investors about China operations
Class action alleges Webull misled investors about China operations

Its SEC filings said one thing - a congressional probe said another.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor